BlueWillow Biologics
Ann Arbor
About BlueWillow Biologics
BlueWillow Biologics operates as a clinical-stage, privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $86.3M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2018)
- Website: bluewillow.com
- Phone: +1 734 302 4000
Industries & Categories
Biotechnology, Health Care, Medical, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/bluewillow-biologics-20202 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.